Orris

Patient age 24 highbp high hb

Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Here is a structured clinical analysis for a 24-year-old with high blood pressure (hypertension) and high hemoglobin (erythrocytosis):

Key Clinical Question: What Unifies These Two Findings?

In a young patient, hypertension + high hemoglobin together should immediately raise the suspicion of an underlying unifying cause rather than two unrelated conditions.

Differential Diagnosis

1. Polycythemia Vera (PV) - Primary Consideration

The classic myeloproliferative disorder where a clonal stem cell mutation (JAK2) drives excessive red cell (and sometimes WBC/platelet) production. Hypertension is a well-recognized feature at presentation.
Presentation clues of PV:
  • Hypertension, thrombosis, pruritus (especially aquagenic - after hot shower), plethora (ruddy face)
  • Erythromelalgia (burning pain in hands/feet)
  • Splenomegaly (typically enlarged at presentation)
  • Headache
  • Budd-Chiari syndrome (10% of cases)
WHO Diagnostic Criteria for PV (need 3 major, OR 2 major + 1 minor):
CriteriaDetails
Major 1Hgb >16.5 g/dL (men) or >16 g/dL (women), OR raised red cell mass (>25% above mean normal predicted)
Major 2BM biopsy shows hypercellularity with prominent erythroid, granulocytic, and megakaryocytic proliferation
Major 3JAK2 V617F or JAK2 exon 12 mutation
Minor 1Subnormal serum erythropoietin (EPO) level
  • JAK2 V617F is positive in 95-98% of PV cases
  • In PV, only red cells are increased (vs. WBC and platelets also raised when stem cell origin)

2. Secondary Erythrocytosis (with Reactive Hypertension)

High EPO states causing secondary polycythemia, where hypertension results from hyperviscosity:
Chronic hypoxia causes:
  • Chronic lung disease
  • Right-to-left cardiopulmonary shunts (congenital heart disease - relevant at age 24)
  • High-altitude habitat
  • Heavy smoking / carbon monoxide poisoning
  • Obstructive sleep apnea (increasingly common in young adults)
  • Renal artery stenosis (also causes hypertension directly)
Hypoxia-independent causes:
  • Androgen/testosterone use (relevant in a 24-year-old male - doping/gym)
  • EPO use
  • EPO-secreting tumors (renal cell carcinoma, hemangioblastoma, hepatocellular carcinoma, etc.)
  • Post-renal transplant

3. Relative (Spurious) Polycythemia

Not a true increase in red cell mass - just plasma volume contraction:
  • Stress, dehydration, aggressive diuretic use, hypertension itself
  • Also called Gaisböck syndrome (stress polycythemia)
  • Characterized by: raised hematocrit but normal total red cell mass

4. Congenital Erythrocytosis (rarer, but relevant at age 24)

  • High-oxygen-affinity hemoglobin variants (reduced p50)
  • VHL mutations (Chuvash polycythemia)
  • EPO receptor gain-of-function mutations
  • HIF2A / PHD2 mutations

Diagnostic Workup

First-line investigations:
  1. CBC with differential - confirm Hgb level; check WBC and platelets (elevated in PV, normal in secondary)
  2. Peripheral blood smear
  3. Serum erythropoietin (EPO) level
    • Low EPO → PV (primary)
    • High EPO → secondary erythrocytosis
  4. JAK2 V617F mutation - if EPO is low or PV suspected
  5. Oxygen saturation (SpO2) - rule out hypoxic cause
  6. Renal function + renal ultrasound / Doppler - renal artery stenosis
  7. LFTs + abdominal ultrasound - splenomegaly, Budd-Chiari
  8. Lipid panel, blood glucose - cardiovascular risk assessment
  9. If JAK2 negative: bone marrow biopsy + JAK2 exon 12 testing
Red flags needing urgent attention:
  • Thrombosis risk is HIGH in PV (most common cause of death is thrombosis at 31%)
  • Hypertension + hyperviscosity = elevated stroke/MI risk

Management Principles

If PV confirmed:

TherapyRole
PhlebotomyTarget hematocrit <45% in men, <42% in women - mainstay of treatment
Low-dose aspirin (100 mg/day)~60% reduction in MI/stroke/cardiovascular death; foundational in all risk groups
HydroxyureaFor high-risk patients (age >60, prior thrombosis, or uncontrolled symptoms)
Interferon-αAlternative to hydroxyurea (especially in younger patients to preserve fertility)
JAK1/2 inhibitor (Ruxolitinib)For hydroxyurea-refractory/intolerant cases
No therapy has been shown to alter disease transformation to myelofibrosis or AML - treatment is aimed at preventing vascular events.

If secondary erythrocytosis:

  • Treat the underlying cause (e.g., CPAP for sleep apnea, stop androgen use, revascularization for renal artery stenosis)
  • Phlebotomy if hematocrit is markedly elevated causing symptoms

Bottom Line

A 24-year-old with hypertension + high hemoglobin needs a secondary hypertension workup with focus on:
  1. Check EPO level first - the most critical differentiating test
  2. If EPO low → test for JAK2 → likely Polycythemia Vera
  3. If EPO high → evaluate for secondary causes (sleep apnea, congenital heart disease, androgen use, renal artery stenosis, EPO-secreting tumor)
  4. If EPO normal with no clear cause → consider relative/spurious polycythemia or congenital erythrocytosis workup
Sources: Goldman-Cecil Medicine, p. 1754; Quick Compendium of Clinical Pathology, 5th ed.; Tintinalli's Emergency Medicine
This is a shared conversation. Sign in to Orris to start your own chat.